Announcement under Regulation 30(LODR) -Resignation of Chief Financial officer

Cfo ResignedManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.7%Reaction day

₹34.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.0%-4.7% vs market

Pharmaceuticals peers, median of 153sector+0.6%-5.3% vs sector

On the reaction day the stock moved 4.7 pts less than Nifty Microcap 250 and 5.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.7+0.0-4.7+0.6-5.3

Next day

-7.1-1.9-5.2-1.3-5.7

-5.1-3.6-1.6-2.8-2.4

-10.9-4.4-6.5-3.6-7.2

-7.9-4.1-3.9-3.8-4.1

-7.2-4.1-3.1-3.7-3.5

-7.6-5.8-1.9-5.1-2.6

15d

-9.7-6.3-3.4-8.0-1.7

-4.0-2.1-1.9-4.2+0.2

-11.8-12.3+0.5-10.9-0.8

-13.9-11.1-2.8-10.8-3.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Pradip Kumar Sharma has resigned from the position of Chief Financial Officer (CFO) of Kimia Biosciences Limited, citing personal reasons. His resignation takes effect from the close of business hours on January 6, 2026. The company has confirmed he was designated as a Key Managerial Personnel under SEBI regulations. The intimation has been made to BSE (scrip code 530313) under Regulation 30 of the SEBI Listing Regulations. The company has not yet disclosed any replacement for the CFO role.

Likely market impact

CFO exits at small-cap companies can create short-term uncertainty around financial reporting and continuity, though the resignation is attributed to personal reasons. Investors should watch for timely appointment of a new CFO to maintain governance stability.